Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer

OBJECTIVES: The purpose of this study was to evaluate whether immune checkpoint inhibitors (ICIs) are associated with an increased risk of major adverse cardiovascular events (MACE) compared with non-ICI therapies in patients with lung cancer. BACKGROUND: ICIs activate the host immune system to targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitturi, Kalyan R., Xu, Jiaqiong, Araujo-Gutierrez, Raquel, Bhimaraj, Arvind, Guha, Ashrith, Hussain, Imad, Kassi, Mahwash, Bernicker, Eric H., Trachtenberg, Barry H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352266/
https://www.ncbi.nlm.nih.gov/pubmed/34396181
http://dx.doi.org/10.1016/j.jaccao.2019.11.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352266/
https://www.ncbi.nlm.nih.gov/pubmed/34396181
http://dx.doi.org/10.1016/j.jaccao.2019.11.013

Ejemplares similares